1. Home
  2. DCO vs SLN Comparison

DCO vs SLN Comparison

Compare DCO & SLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DCO
  • SLN
  • Stock Information
  • Founded
  • DCO 1849
  • SLN 1994
  • Country
  • DCO United States
  • SLN United Kingdom
  • Employees
  • DCO N/A
  • SLN N/A
  • Industry
  • DCO Military/Government/Technical
  • SLN Biotechnology: Pharmaceutical Preparations
  • Sector
  • DCO Industrials
  • SLN Health Care
  • Exchange
  • DCO Nasdaq
  • SLN Nasdaq
  • Market Cap
  • DCO 919.0M
  • SLN 842.4M
  • IPO Year
  • DCO N/A
  • SLN N/A
  • Fundamental
  • Price
  • DCO $66.65
  • SLN $12.70
  • Analyst Decision
  • DCO Strong Buy
  • SLN Strong Buy
  • Analyst Count
  • DCO 4
  • SLN 4
  • Target Price
  • DCO $73.00
  • SLN $61.50
  • AVG Volume (30 Days)
  • DCO 102.3K
  • SLN 184.3K
  • Earning Date
  • DCO 11-07-2024
  • SLN 11-14-2024
  • Dividend Yield
  • DCO N/A
  • SLN N/A
  • EPS Growth
  • DCO 41.24
  • SLN N/A
  • EPS
  • DCO 2.00
  • SLN N/A
  • Revenue
  • DCO $781,490,000.00
  • SLN $21,773,221.00
  • Revenue This Year
  • DCO $5.11
  • SLN N/A
  • Revenue Next Year
  • DCO $6.64
  • SLN $104.98
  • P/E Ratio
  • DCO $33.38
  • SLN N/A
  • Revenue Growth
  • DCO 3.78
  • SLN N/A
  • 52 Week Low
  • DCO $47.53
  • SLN $8.94
  • 52 Week High
  • DCO $70.05
  • SLN $27.72
  • Technical
  • Relative Strength Index (RSI)
  • DCO 57.06
  • SLN 15.31
  • Support Level
  • DCO $66.35
  • SLN $17.11
  • Resistance Level
  • DCO $69.08
  • SLN $18.24
  • Average True Range (ATR)
  • DCO 2.04
  • SLN 0.89
  • MACD
  • DCO 0.59
  • SLN -0.49
  • Stochastic Oscillator
  • DCO 69.99
  • SLN 1.06

About DCO Ducommun Incorporated

Ducommun Inc provides engineering & manufacturing services for high-performance products & high-cost-of failure applications used primarily in the aerospace and defense, industrial, medical & other industries. The company's reportable segments are Structural Systems & Electronic Systems. Structural Systems designs, engineers and manufactures various sizes of complex contoured aerostructure components and assemblies and supplies composite and metal bonded structures and assemblies. Electronic Systems designs, engineers and manufactures high-reliability electronic and electromechanical products used in worldwide technology-driven markets including A&D and Industrial end-use markets. It generates maximum of its revenue from the Electronic Systems.

About SLN Silence Therapeutics Plc American Depository Share

Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid. its pipeline products are; SLN360 therapy designed to temporarily block a specific gene's message that would otherwise trigger an unwanted effect. By silencing the LPA gene, the levels of Lp(a) are lowered, which in turn is expected to lower the risks of heart diseases, heart attacks, and strokes, and SLN124 therapy aims to temporarily silence TMPRSS6, a gene that prevents the liver from producing a particular hormone that controls iron levels in the body hepcidin. As hepcidin increases, iron levels in the blood are expected to decrease, which may increase the production of healthy red blood cells, thereby reducing anemia.

Share on Social Networks: